This webinar explored the cutting-edge RNA drug delivery systems, preclinical trends, and clinical advancements shaping the future of therapeutics. Watch the recording on-demand to gain insight into the commercial landscape and key delivery systems, with expert opinions from CDMOs and drug developers.
Webinar Leaders
House Speaker
Ioana Panait
Senior Research Analyst
Beacon
House Speaker
Sophia Shamsi
Senior Market Analyst
Hanson Wade Intelligence
Moderator
Nattasha Sidhu
Account Manager
Beacon
Speak with industry experts
What is Beacon RNA?
Beacon RNA is a manually curated database solution that includes clinical trial and drug data for preclinical, active, approved, and discontinued:
- Oligonucleotide-based therapies
- mRNA-Based Therapies
- Ribozyme Therapies
- gRNA-Mediated Gene Editing Therapies
- RNA-Targeted Small Molecules
Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.
Who are Hanson Wade Intelligence?
Outsource your competitive intelligence to Hanson Wade Intelligence and have our analysts support your market landscaping and competitive benchmarking.
Hanson Wade Intelligence are modality experts with multi-project experience in preclinical and clinical evaluation of ADCs, Cell and Gene Therapy, RNA, Protein Degraders and much more. With strong primary and secondary research skills, Hanson Wade Intelligence is ideally positioned to be your CI partner.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
